Back to Archived Journals » Comparative Effectiveness Research » Volume 7

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China

Total article views   HTML views PDF downloads Totals
10,866 Dovepress* 10,866+ 811 11,677
Totals 10,866 811 11,677
*Since 23 January 2017

View citations on Google Scholar